Background: IMV-M is a MUC16 × DR5 bispecific antibody that has demonstrated MUC16-selective antitumor activity. However, it remained unclear whether multisite binding to MUC16 is required for cytotoxicity, and whether circulati... ...

请注册登录后继续浏览